Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/1/2021
Bayer Signs Strategic Alliance MOU with China Alliance for Rare Diseas...
3/1/2021
Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
3/1/2021
Eisai Secures Anti-Insomnia Drug Dayvigo in Hong Kong
2/26/2021
241 A Share-Listed Chinese MedPharm Cos Release 2020 Performance Guida...
2/26/2021
Recent Executive Moves
2/26/2021
NMPA Announces Package Insert Revision of Misoprostol Tablets
2/26/2021
CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...
2/25/2021
AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...
2/25/2021
Snapshot of BMI System Financial Performance in 2020
2/25/2021
Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...
2/25/2021
Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...
2/24/2021
Review of Chinese Import Chemical Drug IND Applications in 2020
2/24/2021
Snapshot of MNC Products in the 2020 NRDL
2/23/2021
Solentim Expands Gglobal Rreach, Opening New Operation in China
2/23/2021
Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor fr...
2/23/2021
Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
2/22/2021
How Foreign Companies Can Break Into China's Biosimilar Market and Rel...
2/22/2021
The Race to the Top: Does China Have What It Takes?
2/22/2021
IHS Markit: China Pharma in the Year of the Ox
2/22/2021
Junshi Bio Wins Chinese Conditional Approval for 2nd Indication for T...
2/20/2021
China Further Promotes TCM Development by Strengthening Scientific Res...
2/19/2021
State Council Issues the Regulation on the Use of Medical Insurance Fu...
2/19/2021
Recent Executive Moves
2/18/2021
Junshi Bio Announces sNDA Acceptance for Toripalimab Combined with Ch...
2/18/2021
2020 Performance of Leading MNC Pharma Companies in China
2/17/2021
U.S. Chamber Releases In-Depth Analysis of U.S.-China Economic Relatio...
2/17/2021
CDE Issues the Technical Guidelines for Similarity Assessment and Indi...
2/12/2021
Recent Executive Moves
2/10/2021
CDE Issues Three Documents for Change Filings of Chemical Drugs and Bi...
2/9/2021
NMPA Revises Packages Inserts of Thiamazole Formulations
Page:
96
/
357
Total number of articles:
10684
:
[First]
[<<]
[94]
[95]
[96]
[97]
[98]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit